{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:41:08Z","timestamp":1789713668538,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sanofi Research & Development (Chilly-Mazarin, France) and the French Alternative Energies and Atomic Energy Commission","award":["#153114"],"award-info":[{"award-number":["#153114"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.neuropharm.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T11:10:48Z","timestamp":1519384248000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches"],"prefix":"10.1016","volume":"133","author":[{"given":"T\u00e2nia C.","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Boukaiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Molg\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Partiseti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Servent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5501-0888","authenticated-orcid":false,"given":"Evelyne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.02.016_bib1","article-title":"Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia","author":"Bell","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib2","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.090034797","article-title":"Sodium channel Na(v)1.6 is localized at nodes of Ranvier, dendrites, and synapses","volume":"97","author":"Caldwell","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib3","article-title":"Sodium channels and pain: from toxins to therapies","author":"Cardoso","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/1535-7163.MCT-16-0326","article-title":"Niclosamide inhibits oxaliplatin neurotoxicity while improving colorectal cancer therapeutic response","volume":"16","author":"Cerles","year":"2017","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0300-9084(00)01174-3","article-title":"Molecular mechanisms of neurotoxin action on voltage-gated sodium channels","volume":"82","author":"Cest\u00e8le","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11064-013-1192-z","article-title":"Intrathecal miR-96 inhibits NaV1.3 expression and alleviates neuropathic pain in rat following chronic construction injury","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib8","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1021\/jm501981g","article-title":"Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications","volume":"58","author":"de Lera Ruiz","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib9","volume":"vol. 8","author":"Deuis","year":"2016"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib10","doi-asserted-by":"crossref","first-page":"39662","DOI":"10.1038\/srep39662","article-title":"Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor","volume":"7","author":"Flinspach","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0896-6273(00)00116-1","article-title":"Nomenclature of voltage-gated sodium channels","volume":"28","author":"Goldin","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib12","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/brain\/123.12.2542","article-title":"Effects of membrane polarization and ischaemia on the excitability properties of human motor axons","volume":"123","author":"Kiernan","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.toxicon.2012.04.337","article-title":"Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads","volume":"60","author":"Klint","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1529-8027.2008.00155.x","article-title":"Assessment of nerve excitability in toxic and metabolic neuropathies","volume":"13","author":"Krishnan","year":"2008","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/09298665113206660119","article-title":"Analgesic effects of huwentoxin-IV on animal models of inflammatory and neuropathic pain","volume":"21","author":"Liu","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib16","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3390\/toxins6082363","article-title":"Synthesis and analgesic effects of \u03bc-TRTX-Hhn1b on models of inflammatory and neuropathic pain","volume":"6","author":"Liu","year":"2014","journal-title":"Toxins"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2013.08.050","article-title":"Analysis of the action of gymnodimine-A and 13-desmethyl spirolide C on the mouse neuromuscular system in\u00a0vivo","volume":"75","author":"Marrouchi","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrd2487","article-title":"Drug development from marine natural products","volume":"8","author":"Molinski","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib20","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.140192","article-title":"A\u00a0new look at sodium channel \u03b2 subunits","volume":"5","author":"Namadurai","year":"2015","journal-title":"Open Biol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbpa.2017.03.004","article-title":"Progress and challenges in the optimization of toxin peptides for development as pain therapeutics","volume":"38","author":"Netirojjanakul","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nature17976","article-title":"Selective spider toxins reveal a role for the NaV1.1 channel in mechanical pain","volume":"534","author":"Osteen","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib24","doi-asserted-by":"crossref","first-page":"47564","DOI":"10.1074\/jbc.M204063200","article-title":"Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin (TTX)-sensitive sodium channel antagonist from Chinese bird spider Selenocosmia huwena","volume":"277","author":"Peng","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173551","article-title":"The structure, dynamics and selectivity profile of a NaV1.7 potency-optimised huwentoxin-IV variant","volume":"12","author":"Rahnama","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2006.121483","article-title":"Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons","volume":"579","author":"Rush","year":"2007","journal-title":"J.\u00a0Physiol. Lond"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib27","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.3390\/toxins2122851","article-title":"Spider-venom peptides as therapeutics","volume":"2","author":"Saez","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.febslet.2013.10.038","article-title":"Permeability characteristics of cell-membrane pores induced by ostreolysin A\/pleurotolysin B, binary pore-forming proteins from the oyster mushroom","volume":"588","author":"Schlumberger","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.toxicon.2010.06.001","article-title":"The marine polyether gambierol enhances muscle contraction and blocks a transient K(+) current in skeletal muscle cells","volume":"56","author":"Schlumberger","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib30","first-page":"23","article-title":"Wie lautet der korrekte Name von Selenocosmia huwena Wang, Peng & Xie, 1993?","volume":"142","author":"Schmidt","year":"2010","journal-title":"Tarantulas World"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13985","article-title":"Differential binding of tetrodotoxin and its derivatives to voltage-sensitive sodium channel subtypes (Nav1.1 to Nav1.7)","author":"Tsukamoto","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2016.11.015","article-title":"NaV 1.7 as a pain target \u2013 from gene to pharmacology","volume":"172","author":"Vetter","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2015.08.047","article-title":"Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA","volume":"101","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib34","doi-asserted-by":"crossref","first-page":"27300","DOI":"10.1074\/jbc.M708447200","article-title":"Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain II voltage sensor in the closed configuration","volume":"283","author":"Xiao","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/mol.114.092338","article-title":"Gating-pore currents demonstrate selective and specific modulation of individual sodium channel voltage-sensors by biological toxins","volume":"86","author":"Xiao","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.02.016_bib38","first-page":"371","article-title":"Toxicity of tetrodotoxin towards mice and rabbits","volume":"32","author":"Xu","year":"2003","journal-title":"Wei Sheng Yan Jiu (Chinese)"},{"key":"10.1016\/j.neuropharm.2018.02.016_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1678-9199-20-18","article-title":"Detection and identification of huwentoxin-IV interacting proteins by biotin-avidin chemistry combined with mass spectrometry","volume":"20","author":"Yu","year":"2014","journal-title":"J.\u00a0Venom. Anim. Toxins Incl. Trop. Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:48:23Z","timestamp":1547138903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"alternative-id":["S002839081830073X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct evidence for high affinity blockade of NaV1.6 channel subtype by huwentoxin-IV spider peptide, using multiscale functional approaches","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}